Susquehanna International Group
PAHC icon

Susquehanna International Group’s Phibro Animal Health PAHC Stock Holding History

Susquehanna International Group’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$415K Sell
7,500
-10,100
-57% -$481K ﹤0.01% 10125
2025
Q4 		$658K Buy
17,600
+12,400
+238% +$504K ﹤0.01% 8178
2025
Q3 		$210K Buy
+5,200
New +$172K ﹤0.01% 10890
2022
Q4 		– Sell
-15,000
Closed -$199K – 13337
2022
Q3 		$199K Buy
+15,000
New +$259K ﹤0.01% 10850
2019
Q3 		– Sell
-6,600
Closed -$210K – 10646
2019
Q2 		$210K Buy
+6,600
New +$207K ﹤0.01% 9042

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Susquehanna International Group's PAHC Position: Q1 2026 in Review

Susquehanna International Group increased its Phibro Animal Health (PAHC) stake by 17% in Q1 2026, buying an estimated $47K and bringing the position to 6,698 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #10400.

Susquehanna International Group first reported a position in PAHC in Q2 2014 and has held it in 22 quarters since. The position peaked at $1.9M in Q3 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Susquehanna International Group held 6,698 shares of Phibro Animal Health worth $370K as of Q1 2026.
  • Susquehanna International Group bought 987 Phibro Animal Health shares in Q1 2026, an estimated $47K.
  • Phibro Animal Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10400 holding.
  • Susquehanna International Group first reported a position in Phibro Animal Health in Q2 2014 and has held it in 22 quarters since.
  • Susquehanna International Group's Phibro Animal Health position peaked at $1.9M in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.